Table 3:
Early postoperative outcomes
| Valve function | Hospital death | Cardiac eventsb | Respiratory events | Neurological events | Renal failurec | Reoperation for bleeding | |
|---|---|---|---|---|---|---|---|
| TAV (n = 87) | Normal (n = 36) | 1 (2.8%) | – | 1 (2.9%) | – | – | 1 (2.9%) |
| Stenosis (n = 12) | – | 1 (8.3%) | – | – | – | 1 (8.3%) | |
| Regurgitation (n = 39) | 2 (5.1%) | 6 (15%) | 5 (13%) | 1 (2.6%) | 4 (10%) | 1 (2.6%) | |
| P (TAV)a | 0.35 | 0.04* | 0.19 | 0.86 | 0.02* | 0.64 | |
| BAV (n = 69) | Normal (n = 10) | – | – | – | – | – | – |
| Stenosis (n = 37) | – | 2 (5.4%) | 1 (2.7%) | – | 1 (2.7%) | – | |
| Regurgitation (n = 22) | – | 1 (4.5%) | 1 (4.5%) | – | 1 (4.5%) | – | |
| P (BAV)a | – | 0.84 | 0.77 | – | 0.56 | – | |
| Overall | 3 (1.9%) | ||||||
| All TAV | 3 (3.4%) | 7 (8%) | 6 (6.9%) | 1 (1.1%) | 4 (4.6%) | 3 (3.4%) | |
| All BAV | – | 3 (4.3%) | 2 (2.9%) | – | 2 (2.9%) | – | |
| P (TAV versus BAV) | 0.25 | 0.27 | 0.22 | 0.55 | 0.45 | 0.25 |
All data are reported as count (percentage). BAV, bicuspid aortic valve; TAV, tricuspid aortic valve.
aANOVA test.
bCardiac events included: atrial fibrillation (4, 2.6%), pericardial effusion (3, 1.9%), pace-maker implantation (2, 1.3%), low output (1, 0.6%).
cNeed for haemofiltration/dialysis.
*indicates statistical significance.